Kubota Glass® Myopia Progression Care Device Launches Monthly Subscription Service "My Vision Program" on April 13th

Kubota Pharmaceutical Holdings Co., Ltd. announced today, April 13, 2026, the launch of "Kubota Glass® My Vision Program," a monthly subscription service for its myopia progression care device, Kubota Glass®. Kubota Glass® is a myopia progression care device developed by ophthalmologist and researcher Ryo Kubota (M.D., Ph.D.). It differs fundamentally from vision correction methods like glasses or contact lenses, and pharmacological approaches like eye drops. The device has been available in the Japanese market since 2022. The "My Vision Program" is designed to lower the barrier to starting myopia care. The service includes an initial fee of ¥39,000 (excluding tax, during campaign period; planned price after campaign ¥50,000) and a monthly fee of ¥12,000 (excluding tax) for 24 months. It can be purchased nationwide via the official website and Tokyo direct store. Fitting and counseling are available at the Tokyo direct store. A "2 for You Campaign" is being held from April 13 (Monday) to June 19 (Friday), 2026, for all applicants of the My Vision Program. Benefits include a 22% discount on the initial fee (¥39,000), an extended free warranty period to 2 years (normally 1 year), and a ¥2,222 Amazon gift card. Kubota Pharmaceutical Holdings Co., Ltd. is a global healthcare company founded by ophthalmologist and researcher Ryo Kubota (M.D., Ph.D.), engaged in the research, development, and commercialization of pharmaceuticals and medical devices, primarily in the ophthalmic field.